These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
420 related articles for article (PubMed ID: 36072790)
21. Novel prognostic matrisome-related gene signature of head and neck squamous cell carcinoma. Huang C; Liang Y; Dong Y; Huang L; Li A; Du R; Huang H Front Cell Dev Biol; 2022; 10():884590. PubMed ID: 36081907 [No Abstract] [Full Text] [Related]
22. Identification of cuproptosis-related subtypes and characterization of the tumor microenvironment landscape in head and neck squamous cell carcinoma. Huang J; Xu Z; Yuan Z; Cheng L; Zhou C; Shen Y J Clin Lab Anal; 2022 Sep; 36(9):e24638. PubMed ID: 36082469 [TBL] [Abstract][Full Text] [Related]
23. Construction of an 11-microRNA-based signature and a prognostic nomogram to predict the overall survival of head and neck squamous cell carcinoma patients. Huang Y; Liu Z; Zhong L; Wen Y; Ye Q; Cao D; Li P; Liu Y BMC Genomics; 2020 Oct; 21(1):691. PubMed ID: 33023466 [TBL] [Abstract][Full Text] [Related]
24. Development and Verification of a novel cuproptosis- and immune-associated based prognostic genetic signature for pancreatic ductal adenocarcinoma. Xu X; Liang JH; Xu QC; Yin XY Clin Res Hepatol Gastroenterol; 2023 Mar; 47(3):102089. PubMed ID: 36707046 [TBL] [Abstract][Full Text] [Related]
25. A novel signature to guide osteosarcoma prognosis and immune microenvironment: Cuproptosis-related lncRNA. Yang M; Zheng H; Xu K; Yuan Q; Aihaiti Y; Cai Y; Xu P Front Immunol; 2022; 13():919231. PubMed ID: 35967366 [TBL] [Abstract][Full Text] [Related]
26. A novel cuproptosis-related lncRNA nomogram to improve the prognosis prediction of gastric cancer. Feng A; He L; Chen T; Xu M Front Oncol; 2022; 12():957966. PubMed ID: 36106123 [TBL] [Abstract][Full Text] [Related]
27. Identification of a cuproptosis-related lncRNA signature to predict the prognosis and immune landscape of head and neck squamous cell carcinoma. Huang J; Xu Z; Yuan Z; Teh BM; Zhou C; Shen Y Front Oncol; 2022; 12():983956. PubMed ID: 36568234 [TBL] [Abstract][Full Text] [Related]
28. A prognostic signature of cuproptosis and TCA-related genes for hepatocellular carcinoma. Zhang Q; Ma L; Zhou H; Zhou Y; Liu S; Li Q Front Oncol; 2022; 12():1040736. PubMed ID: 36324575 [TBL] [Abstract][Full Text] [Related]
29. Identification of a metabolic reprogramming-related signature associated with prognosis and immune microenvironment of head and neck squamous cell carcinoma by in silico analysis. Qiang W; Dai Y; Xing X; Sun X Cancer Med; 2022 Aug; 11(16):3168-3181. PubMed ID: 35301800 [TBL] [Abstract][Full Text] [Related]
30. A cuproptosis-related lncRNA signature predicts the prognosis and immune cell status in head and neck squamous cell carcinoma. Zheng X; Zheng D; Zhang C; Guo H; Zhang Y; Xue X; Shi Z; Zhang X; Zeng X; Wu Y; Gao W Front Oncol; 2023; 13():1055717. PubMed ID: 37538124 [TBL] [Abstract][Full Text] [Related]
31. Cuproptosis-related lncRNA SNHG16 as a biomarker for the diagnosis and prognosis of head and neck squamous cell carcinoma. Han B; Li S; Huang S; Huang J; Wu T; Chen X PeerJ; 2023; 11():e16197. PubMed ID: 37846311 [TBL] [Abstract][Full Text] [Related]
32. Clinical significance and immune landscape of cuproptosis-related lncRNAs in kidney renal clear cell carcinoma: a bioinformatical analysis. Li D; Wu X; Song W; Cheng C; Hao L; Zhang W Ann Transl Med; 2022 Nov; 10(22):1235. PubMed ID: 36544675 [TBL] [Abstract][Full Text] [Related]
33. A Cuproptosis-Related Gene Model For Predicting the Prognosis of Clear Cell Renal Cell Carcinoma. Mei W; Liu X; Jia X; Jin L; Xin S; Sun X; Zhang J; Zhang B; Chen Y; Che J; Ma W; Ye L Front Genet; 2022; 13():905518. PubMed ID: 36092880 [TBL] [Abstract][Full Text] [Related]
34. Development of an Immunogenomic Landscape-Based Prognostic Index of Head and Neck Squamous Cell Carcinoma. Long J; Zhang S; Zeng X; Ouyang Y; Wang Y; Hu Z; Ye Y; Wu W; Jin F; Zhou S; Zeng Z Front Mol Biosci; 2020; 7():586344. PubMed ID: 33330624 [TBL] [Abstract][Full Text] [Related]
35. A composite score based on immune-related gene prognostic index and m Yang Y; Cai Z; Huang K; Li M; Wang X; Lin Y; Chen S; Yang Z; Lin Z Front Genet; 2023; 14():1061569. PubMed ID: 36845378 [No Abstract] [Full Text] [Related]
36. Development and Validation of an ADME-Related Gene Signature for Survival, Treatment Outcome and Immune Cell Infiltration in Head and Neck Squamous Cell Carcinoma. Tang X; Li R; Wu D; Wang Y; Zhao F; Lv R; Wen X Front Immunol; 2022; 13():905635. PubMed ID: 35874705 [TBL] [Abstract][Full Text] [Related]
37. A novel cuproptosis-related gene signature for predicting prognosis in cervical cancer. Lei L; Tan L; Sui L Front Genet; 2022; 13():957744. PubMed ID: 36092887 [No Abstract] [Full Text] [Related]
38. Identification and validation of cuproptosis-related LncRNA signatures as a novel prognostic model for head and neck squamous cell cancer. Liu X; Cheng W; Li H; Song Y Cancer Cell Int; 2022 Nov; 22(1):345. PubMed ID: 36369058 [TBL] [Abstract][Full Text] [Related]
39. Development and validation of a GRGPI model for predicting the prognostic and treatment outcomes in head and neck squamous cell carcinoma. Han F; Wang HZ; Chang MJ; Hu YT; Liang LZ; Li S; Liu F; He PF; Yang XT; Li F Front Oncol; 2022; 12():972215. PubMed ID: 36713509 [TBL] [Abstract][Full Text] [Related]
40. A model of seven immune checkpoint-related genes predicting overall survival for head and neck squamous cell carcinoma. Song D; Tian J; Han X; Li X Eur Arch Otorhinolaryngol; 2021 Sep; 278(9):3467-3477. PubMed ID: 33449165 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]